General Western Blot Reagents
Abcam YM-01 (YM-1), allosteric Hsp70 modulator, 10MG
MW 417.97 g/mol, Purity >98%. Allosteric Hsp70 modulator. Potent anti-tau agent. MKT-077 analog. Promotes triage functions of Hsp70. Rapidly and potently reduces tau levels ex vivo. Shows antitumor effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human BD-3 peptide, 100UG
Human BD-3 peptide is a Synthetic blocking peptide. >95% purity and suitable for BL.
Protein/ Peptide/ Enzyme Synonyms: BD3, DEFB103, DEFB3, DEFB103B, DEFB103A, Beta-defensin 103, Beta-defensin 3, Defensin-like protein, BD-3, DEFB-3, HBD3, hBD-3
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human Histone H3 (tri methyl K9) peptide, 1MG
Human Histone H3 (tri methyl K9) peptide is a Synthetic blocking peptide. >90% purity and suitable for BL.
Protein/ Peptide/ Enzyme Synonyms: H3FA, HIST1H3A, H3C2, H3FL, HIST1H3B, H3C3, H3FC HIST1H3C, H3C4, H3FB, HIST1H3D, H3C6, H3FD, HIST1H3E, H3C7, H3FI, HIST1H3F, H3C8, H3FH, HIST1H3G, H3C10, H3FK, HIST1H3H, H3C11, H3FF, HIST1H3I, H3C12, H3FJ, HIST1H3J, H3C1, H3FC, HIST1H3C, Histone H3.1, Histone H3/a, Histone H3/b, Histone H3/c, Histone H3/d, Histone H3/f, Histone H3/h, Histone H3/i, Histone H3/j, Histone H3/k, Histone H3/l, H3K9me3
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam Melatonin, Endogenous hormone agonist at MT1 and MT2 receptors, 50MG
MW 232.28 Da, Purity >99%. Agonist at melatonin MT1 and MT2 receptors. Endogenous hormone important in the control of the circadian rhythm. Wide range of pathophysiological functions including antioxidative and immunomodulatory effects.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Polygodial, TRPA1 agonist, 25MG
MW 234.33 Da, Purity >97%. Selective TRPA1 agonist (EC₅₀ = 400 nM). Antinociceptive in vivo. Inhibits mitochondrial ATPase (IC₅₀ = 15 μM). Antifungal.
The product is subject to the following: Abcam Restricted Use Statement
Abcam 2'-Deo x ycytidine 5'-monophosphate, UMP/CMP kinase substrate, 250MG
MW 307.2 g/mol. Nucleoside monophosphate used as a substrate of uridine monophosphate (UMP)/cytidine monophosphate (CMP) kinase (EC 2.7.4.4) to form dCDP which upon phosphorylation to dCTP supports DNA biosynthesis.
The product is subject to the following: Abcam Restricted Use Statement
Abcam DL-Lactic acid lithium salt, racemic mi x ture, 50G
MW 96.01 g/mol, Purity >99%. Lithium salt of lactate acid. Racemic mixture of DL isomers. Lactic acid is an α hydroxyl carboxylic acid produced from pyruvate by the enzyme lactate dehydrogenase (LDH), and is a fermentation acid from milk or carbohydrates.
The product is subject to the following: Abcam Restricted Use Statement
Abcam n-Octyl-beta-D-maltopyranoside, non-ionic detergent, 1G
MW 454.4 g/mol, Purity >98%. Water soluble non-ionic detergent suitable for solubilization and isolation of membrane proteins.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Pluronic F-127, Detergent, 10% Solution, Sterile-Filtered, 25ML
This product is manufactured by BioVision, an Abcam company and was previously called 2731 Pluronic F-127, MegPure™ Detergent, 10% Solution, Sterile-Filtered.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human c-Myc peptide, 1MG
Human c-Myc peptide is a Synthetic blocking peptide. Suitable for BL.
Protein/ Peptide/ Enzyme Synonyms: BHLHE39, MYC, Myc proto-oncogene protein, Class E basic helix-loop-helix protein 39, Proto-oncogene c-Myc, Transcription factor p64, bHLHe39
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam Atpenin A5, ubiquinone-binding site mitochondrial comple x II inhibitor, 1MG
MW 366.2 Da, Purity >95%. Highly selective, potent ubiquinone-binding site mitochondrial complex II inhibitor (IC₅₀ values are 12 and 3.7 nM for nematode and mammalian mitochondria respectively). Stimulates mitochondrial KATP channels. Shows anti-ischemic and cardioprotective effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam AMQI (7-Aceto x y-1-methylquinolinium iodide), Fluorogenic cholinesterase substrate, 1G
MW 329.13 Da, Purity >98%. Fluorogenic cholinesterase substrate. Hydrolyses to highly fluorescent 7-hydroxy-1-methyl quinolinium iodide.
The product is subject to the following: Abcam Restricted Use Statement
Abcam MIRA-1, p53 inducer, 50MG
MW 183.16 Da, Purity >99%. Novel, nontoxic and selective p53 inducer. Antitumor agent. Promotes tumor cell apoptosis in a mutant p53-dependent manner (IC₅₀ = 10 μM) and prolongs survival. Active in vivo and in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam D-Fructose 6-phosphate disodium salt hydrate, Glycolytic intermediate, 500MG
MW 304.1 g/mol, Purity >98%. Sugar intermediate of the glycolytic pathway produced by the isomerization of glucose-6-phosphate by phosphoglucoisomerase.
The product is subject to the following: Abcam Restricted Use Statement
Abcam PR 619, DUB inhibitor, 25MG
MW 223.3 Da, Purity >99%. Cell-permeable, non-selective and reversible DUB inhibitor (IC₅₀ values are 5 to 20 μM). Induces polyubiquitinated protein accumulation in cells without directly affecting proteasome activity. Activates autophagy.
The product is subject to the following: Abcam Restricted Use Statement